Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout. - Wikidata - wikimedia - TriplyDB

Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.

Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.

http://www.wikidata.org/entity/Q37070180

about

Hyperuricaemia with deposition: latest evidence and therapeutic approach Fenbendazole improves pathological and functional recovery following traumatic spinal cord injury.The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes.Colchicine: old and new Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims.Microtubule-mediated defects in junctophilin-2 trafficking contribute to myocyte transverse-tubule remodeling and Ca2+ handling dysfunction in heart failure.Evaluation and treatment of gout as a chronic disease.Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease.Colchicine for secondary prevention of cardiovascular disease.Advances in pharmacotherapy for the treatment of gout.Hyperuricemia, gout, and cardiovascular disease: an update.Colchicine as an anti-inflammatory and cardioprotective agent.Investigational new drugs for the treatment of acute coronary syndrome.Chronic heart failure: Ca(2+), catabolism, and catastrophic cell death.Inflammatory cytokines in atherosclerosis: current therapeutic approaches.Colchicine in cardiovascular disease: an ancient drug with modern tricks.Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.What's Old is New Again - A review of the current evidence of colchicine in cardiovascular medicine.Impact of allopurinol on risk of myocardial infarction.Anti-inflammatory drugs as promising cardiovascular treatments.The safety of treatment options available for gout.Colchicine: an ancient drug with novel applications.[Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].Is There a Role for Colchicine in Acute Coronary Syndromes?Update on colchicine, 2017.

P2860

Q26775759-7770F8B3-0495-4AD8-BDBA-4267491A6966 Q33723584-9DE8A87E-82CD-4DA8-BED1-79B1FB228A60 Q33838927-3C145207-CB70-468E-9818-AE3285BD9EF3 Q36306524-2E08D184-246F-488E-817F-4C83DFED1558 Q36384995-7D55907C-8AD6-4290-B739-AACF86A0FD23 Q36578681-31E657F9-4138-4C7A-ABC0-97BBBD140AC6 Q37308677-A365655C-84A5-4177-A1AA-5F6A28EED33E Q37735504-A9C0B2E3-B13B-4342-BAD2-82B5F530384A Q38056075-277A2402-6230-4F96-BFB5-8F545CD99D8D Q38137848-2F297135-F275-4D72-ADA0-F005F39C3C6D Q38178536-B0B3F375-672A-45E4-89C2-DC6FFE1E0A7F Q38303416-4343B7D3-5E5A-403E-8A5C-2BDB2F979CD2 Q38367776-9AF48C8D-1193-41F9-8713-CF0D2E3EB088 Q38560160-994F6278-093A-49BF-B09F-9BCE213616F4 Q38594609-47576CC5-281A-48DF-A055-A283F526EFAB Q38699105-01156756-9546-43A0-9C42-F7898F7F1E01 Q38722298-250BE667-7288-48F0-8D27-01F1757639A4 Q38780826-BB356332-C229-480C-8041-9BD3AFB767D2 Q38786058-061B8DCB-A246-4651-90C8-BB3B07CFB56A Q38985092-FB5026AE-F8DF-432D-9600-FC7F13A3B5AF Q39033643-B12288EB-9A01-417A-94C0-32B2A4A5FD73 Q39051784-DEDDE8D3-2390-4CAF-A152-D81D0F65B371 Q39092018-4959FC44-5235-42A6-8333-277214B47D55 Q40042238-93BE70F2-33A5-485E-BAE6-ECEF9FA1D1E8 Q41746637-29EFD731-9348-4888-BA35-E9E66DA04E9C Q43228025-30A96944-E6BE-4BE9-BBCC-8033E7D35972 Q47177948-ADBA893E-A488-4C0D-A59F-77C34C63DF67

P2860

Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout.

http://www.wikidata.org/entity/Q37070180

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Colchicine use is associated w ...... arction in patients with gout.

@en

Colchicine use is associated w ...... arction in patients with gout.

@nl

type

label

Colchicine use is associated w ...... arction in patients with gout.

@en

Colchicine use is associated w ...... arction in patients with gout.

@nl

prefLabel

Colchicine use is associated w ...... arction in patients with gout.

@en

Colchicine use is associated w ...... arction in patients with gout.

@nl

P1433

Q37070180-9A75FF1A-6784-4065-9B4A-292C89D623A0

P1476

Q37070180-9308E5D2-41EC-4C1E-831A-30B48D210AB5

P2093

Q37070180-1AD5D047-F6FD-46C7-B02C-D3A4B46EF4EB

Q37070180-3ADA7783-5EF6-4032-B86D-8793A73C41F2

Q37070180-4E707DAB-AD21-4987-BB46-ACC84EFDBD7B

Q37070180-C1306A8D-20F1-4805-9BC6-4E8283718B40

Q37070180-CE9D2E5F-A13E-43DF-91E9-251617AE9195

P2860

Q37070180-042B8E77-3F69-4D21-A25E-5E7FEA34E385

Q37070180-0756BBD7-D844-4E35-B0E2-23A90FEC35B8

Q37070180-0B73F307-9490-4715-8029-451B993FED81

Q37070180-11D564F9-BC55-44A2-8FD0-A7D298604688

Q37070180-17A6114E-5545-4686-A252-7A065048B5BB

Q37070180-204DD706-E10A-4AA7-AB77-C1D3A54A75D8

Q37070180-21E9FF6D-1099-42BE-BF65-88BE9F93DA0B

Q37070180-293432A5-D86F-47BD-84CB-754C1E170813

Q37070180-342C9465-990D-413A-AF4E-31755297F552

Q37070180-394E8B00-BBFE-428A-A11F-E5032F1DA764

P304

Q37070180-6414B4D4-C118-4996-ABDF-A98C5FEFE71D

P31

Q37070180-92563C20-70F4-4E77-9720-9AD7F380E351

P356

Q37070180-2F02E0D7-8546-4DF4-889A-7C449C841120

P407

Q37070180-31AE84A6-8651-43A0-82D7-EEB16CF2F7DB

P433

Q37070180-09A69792-4F87-44E0-9A2A-6AE1F316221A

P478

Q37070180-62A3FB3D-5C9F-4ACF-A138-39EBF38BD4AE

P50

Q37070180-4C22FDEB-C1D4-430A-8CC8-CF59A50ECAA8

Q37070180-AFD63F2E-933A-47B7-B48C-5C4D6C1B6212

Q37070180-B5C26EB6-BF0F-4ABA-AC21-21D6718FD67C

Q37070180-F07F8E20-FA28-41EA-8029-C89A5A3CAA7C

P577

Q37070180-708F00BF-1AC2-42D1-9105-A3D6941ACD6A

P698

Q37070180-17D1AEBC-8FD8-4046-A010-A9AC6C75203A

P921

Q37070180-28E9F0E8-C7AF-4BF8-8137-8A5E5DA0FB9D

P932

Q37070180-1B887B3A-C359-41ED-867B-A99C67641191

P356

P1433

The Journal of Rheumatology

P1476

Colchicine use is associated w ...... farction in patients with gout

@en

P2093

Daria B Crittenden

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Greenberg

http://www.w3.org/2001/XMLSchema#string

Laura Schneck

http://www.w3.org/2001/XMLSchema#string

R Aaron Lehmann

http://www.w3.org/2001/XMLSchema#string

Robert T Keenan

http://www.w3.org/2001/XMLSchema#string

P2860

Extracellular DNA traps promote thrombosis.

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk

Gout-associated uric acid crystals activate the NALP3 inflammasome

Gout and the risk of acute myocardial infarction

Update on colchicine and its mechanism of action

Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease

Inflammation, atherosclerosis, and coronary artery disease

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Progress and challenges in translating the biology of atherosclerosis

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.

P304

1458-1464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3899/JRHEUM.111533

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P50

Steven P Sedlis

Bruce N Cronstein

Michael Pillinger

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22660810

http://www.w3.org/2001/XMLSchema#string

P921

P932

3733459

http://www.w3.org/2001/XMLSchema#string